Actos Bladder Cancer Litigation Attorneys
West Palm Beach and Palm Beach County
Actos (Pioglitazone) manufactured by Takeda Pharmaceutical Co. and co-marketed by Eli Lilly and Company, is a medication commonly prescribed to help control blood levels in adults with Type II diabetes. In 2010, more than 2.3 million patients filled prescriptions for Actos.
Research suggested that there may be a link between Actos usage and bladder cancer. According to court documents, internal studies at Takeda showed that the Actos was linked to blood cancer as early as 2004, but Takeda didn’t alert the Food & Drug Administration (FDA) until seven years later.
Takeda failed to adequately warn patients of the risk of taking Actos which lead to FDA action including enforcing a Black Box warning label informing consumers of the potential risk involved in taking Actos.
On June 15, 2011, the FDA released a safety communication informing the public that using Actos for more than a year may be associated with an increased risk of bladder cancer and recommended that patients with bladder cancer to avoid the drug.
Patients who developed bladder cancer may experience the following symptoms:
- Consistent need to urinate
- Blood in urine
- Abdominal or lower back pain
- Painful urination
Other Actos side effects can include:
- Congestive heart failure
- Liver failure
- Bone fractures
- Macular edema
The attorneys at Murray Guari are investigating potential lawsuits on behalf patients who have taken the diabetic medication Actos for more than a year and developed blood cancer.
If you were taking Actos and suffer from bladder cancer or other side effects, and would like to learn more about your legal rights, please call our Defect Drug Lawyers or contact us here for a free consultation.